MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Inventory$3,611K Accounts receivable, net$55,789K Prepaid expenses andother current assets$13,227K Cash and cashequivalents$135,156K Other long-termassets$1,693K Inventory, non-current$24,101K Restricted cash$2,862K Operating leaseright-of-use assets$2,694K Property and equipment,net$1,156K Total current assets$207,783K Total assets$240,289K Accumulated deficit-$1,463,110K Total liabilities andstockholders' deficit$240,289K Total stockholders'deficit-$422,534K Additional paid-in capital$1,040,570K Common stock, 0.0001par value...$6K Total liabilities$662,823K Other long-termliabilities$11,500K Operating leaseliabilities$2,123K Revenue interestfinancing liability$348,984K Long-term debt, net ofdiscount$207,093K Total currentliabilities$93,123K Current portion ofrevenue interest...$24,344K Operating leaseliabilities, current$591K Accrued interest$1,764K Accrued expenses$65,349K Accounts payable$1,075K
Balance Sheet
source: myfinsight.com

Phathom Pharmaceuticals, Inc. (PHAT)

Phathom Pharmaceuticals, Inc. (PHAT)